The log of the linear regression slope was 0.22 (90% CI 0.02, 0.41), indicating that this trend was marginally statistically significant.
← all excerpts
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function.
1
—
—